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2Short Abstract:
We report on a smart application of carbon nanotubes for kinetic stabilization of lipid
particles that contain self-assembled nanostructures in their cores. The preparation of lipid
particles requires rather low concentrations of carbon nanotubes permitting their use in
biomedical applications such as drug delivery.
Long Abstract:
We present a facile method to prepare nanostructured lipid particles stabilized by carbon
nanotubes (CNTs). Single-walled (pristine) and multi-walled (functionalized) CNTs are used
as stabilizers to produce Pickering type oil-in-water (O/W) emulsions. Lipids namely,
Dimodan U and Phytantriol are used as emulsifiers, which in excess water self-assemble into
the bicontinuous cubic Pn3m phase. This highly viscous phase is fragmented into smaller
particles using a probe ultrasonicator in presence of conventional surfactant stabilizers or
CNTs as done here. Initially, the CNTs (powder form) are dispersed in water followed by
further ultrasonication with the molten lipid to form the final emulsion. During this process
the CNTs get coated with lipid molecules, which in turn are presumed to surround the lipid
droplets to form a particulate emulsion that is stable for months. The average size of CNT-
stabilized nanostructured lipid particles is in the submicron range, which compares well with
the particles stabilized using conventional surfactants. Small angle X-ray scattering data
confirms the retention of the original Pn3m cubic phase in the CNT-stabilized lipid
dispersions as compared to the pure lipid phase (bulk state). Blue shift and lowering of the
intensities in characteristic G and G bands of CNTs observed in Raman spectroscopy
characterize the interaction between CNT surface and lipid molecules. These results suggest
that the interactions between the CNTs and lipids are responsible for their mutual
stabilization in aqueous solutions. As the concentrations of CNTs employed for stabilization
are very low and lipid molecules are able to functionalize the CNTs, the toxicity of CNTs is
expected to be insignificant while their biocompatibility is greatly enhanced. Hence the
present approach finds a great potential in various biomedical applications, for instance, for
developing hybrid nanocarrier systems for the delivery of multiple functional molecules as
in combination therapy or polytherapy.
3Introduction:
Over the last few decades, nanotechnology has emerged as a powerful tool especially in the
field of preclinical development of medicine to combat notorious diseases such as cancer1.
In this context, nanoscale structures with size <1000 nm are extensively explored as delivery
vehicle of various active biomolecules such as drugs, proteins, nucleic acids, genes and
diagnostic imaging agents1-4. These biomolecules are either encapsulated within the
nanoparticles or conjugated onto the surface of nanoparticles and are released at the site of
action by triggers such as pH or temperature5,6. Although extremely small in size, the large
surface area of these nanoparticles proves to be greatly advantageous for targeted delivery
of active biomolecules. The control over the particle size and biocompatibility is of utmost
importance in order to optimize the therapeutic efficacy and hence the applicability of
nanoparticles7,8. Lipids9-13, polymers14,15, metals16,17 and carbon nanotubes18,19 have been
commonly employed as nanocarriers for various biomedical and pharmaceutical
applications.
Moreover, nanocarrier applications based on lipid self-assembled nanostructures have a
wide significance in many other disciplines including food and cosmetic industries20,21. For
instance, they are used in protein crystallization22, separation of biomolecules23, as food
stabilizers e.g. in desserts24, and in the delivery of active molecules such as nutrients,
flavours and perfumes25-31. Self-assembled lipid nanostructures not only have the ability to
release bioactive molecules in a controlled and targeted fashion32-38 but they are also able
to protect the functional molecules from chemical and enzymatic degradation39,40. Although
planar fluid bilayer is the most common nanostructure formed by amphiphilic lipid
molecules in presence of water, other structures such as hexagonal and cubic are also
commonly observed20,41,42. The type of nanostructure formed depend upon the lipids
molecular shape structure, the lipid composition in water as well as on the physico-chemical
conditions employed such as temperature and pressure43. The applicability of non-planar
lipid nanostructures especially that of cubic phases, is restricted because of their high
viscosity and non-homogeneous domain consistency. These problems are overcome by
dispersing the lipid nanostructures in large amount of water to form oil-in-water (O/W)
emulsions containing micron or submicron sized lipid particles. In this manner, a suitable
product of low viscosity can be prepared while retaining the original lipid self-assembled
structure inside the dispersed particles. The formation of these internally self-assembled
particles (abbreviated as ISAsomes44 e.g. cubosomes from cubic phases and hexosomes
from hexagonal phases) commonly requires a combination of an high energy input step and
the addition of stabilizers such as surfactants or polymers. Recent research in this direction
demonstrates the application of various solid particles45 including silica nanoparticles46,
clay47-49 and carbon nanotubes50 for the stabilization of aforementioned emulsions, suitably
termed as Pickering51 or Ramsden-Pickering emulsions52.
In recent years, carbon based nanostructures such as single-walled carbon nanotubes
(SWCNTs), multi-walled carbon nanotubes (MWCNTs) and fullerenes have received a great
deal of attention as novel biomaterials53,54. The main concerns are their toxicity55-58, water
insolubility59 and hence their biocompatibility56. An efficient way to tackle these issues is the
surface functionalization using non-toxic and biocompatible molecules such as lipids. In
presence of water, lipids interact with CNTs in a manner that hydrophobic surface of CNTs is
shielded from polar aqueous medium whereas the lipid hydrophilic head groups aid their
4solubility or dispersion in water60,61. Lipids are integral constituents of cellular organelles as
well as some food materials, therefore their decoration should ideally decrease the in vivo
toxicity of CNTs. Biomedical applications based independently on CNTs18,19 and lipid
nanostructures9-13 are under extensive development but the applications that combine
properties of the two are not yet well-explored.
In this work, we employ two different types of lipids and three types of CNTs of which
SWCNTs are in the pristine form whereas MWCNTs are functionalized with hydroxyl and
carboxylic groups. We have used very low concentrations of CNTs to prepare the dispersions
whose stability depends upon several factors e.g. the type of lipid, type of CNT, ratio of lipid
to CNT used, as well as on the sonication parameters employed such as power and duration.
This video protocol provides technical details of a method of kinetically stabilizing lipid
nanoparticles using various CNT-stabilizers.
Protocol:
Caution: CNTs used in this work are in the nanoparticulate form which may have additional
hazards compared to their bulk counterparts. Inhalation of graphite, both natural and
synthetic, can cause pneumoconiosis62 similar to coal worker's pneumoconiosis. Moreover,
there have been concerns relating to the toxicity of carbon based nanostructures and some
of the previous studies suggest acute and chronic toxicity associated with the inhalation of
CNTs63-68. Hence, avoid inhalation of the fine CNT powder and handle it with great care. If
inhaled, move to fresh air. If breathing is difficult, use pure oxygen instead and seek medical
consultation. Solution/dispersion formulations of CNTs are rather safe to handle.
Caution: Lipids and surfactants used in this study are food-grade materials and thus non-
hazardous in general, but they are irritant to eyes and skin, and also highly flammable.
Hence, please use all appropriate safety practices such as use of engineering controls (fume
hood) and personal protective equipment (safety glasses, gloves, lab coat, full length pants,
closed-toe shoes) when handling or preparing nanoparticle samples. In case of contact with
skin or eyes, immediately flush skin or eyes with plenty of water for at least 15 min. Seek
medical advice if required.
1. Preparation of lipid/water bulk phases
Caution: Store the lipids in the refrigerator at 4 °C. Pure grade lipids should be stored in the
freezer (-20 °C). Aliquot them into small glass vials to avoid contamination of the whole
stock and convenience of handling. Other chemicals including CNTs and surfactants can be
stored at room temperature but keep them away from direct sunlight.
1.1 Keep lipids, i.e. Dimodan U (DU) and Phytantriol (PT) at room temperature for 15-20
min prior to opening the bottle/vial lid in order to avoid moisture condensation. (Note: DU is
a distilled glyceride comprising 96% monoglycerides and the rest are diglycerides and free
fatty acids. Two major monoglyceride components in DU are linoleate (62%) and oleate
(25%). Hence the hydrophobic part of DU mainly contains C18 chains (91%), the exact
composition of which is as follows; C18:2 (61.9%), C18:1 (24.9%), and C18:0 (4.2%), where
C18 indicates 18C-chain and the number after colon indicates number of C=C bonds. PT is a
5mixture of 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol optical isomers. It does not contain
an ester functional group but consists of highly branched phytanyl tail with a tri-hydroxy
headgroup. Both of DU and PT form cubic phases in presence of excess water which is also
the case for the cores of stabilized lipid particles13, 45).
1.2 Melt the lipids by putting vials in a hot water bath or a beaker containing water
maintained above 60 °C (heating magnetic stirrer: 230 V, 50 Hz, 630 W or similar to be used
to heat the water in a beaker).
1.2. Alternatively heat vials using block heaters. Do not heat the lipid containing vials
directly on the hot plate in order to avoid temperature gradient and subsequent lipid
decomposition.
1.3 Weigh 500 mg of the molten lipid, in previously weighed microcentrifuge tube (with
conical snap cap, 1.5 mL), using a Pasteur glass pipette with a latex bulb.
1.4 ĚĚ ? ? ?ŵ>ŽĨƵůƚƌĂƉƵƌĞǁĂƚĞƌ ?ǁĂƚĞƌƌĞƐŝƐƚŝǀŝƚǇA? ? ? Dɏ ?Đŵ ?ƚŽƚŚĞĂďŽǀĞ
microcentrifuge tube.
1.5 Mix the components manually for 15 min using tiny (custom-built) spatula. Make
such a spatula by flattening the sharp end of a syringe needle (0.9 mm x 40 mm cannula
length) using a plier.
1.6 Centrifuge the lipid/water mixture for 10 min at a speed of 2000 x g. Again stir the
mixture manually for 10 min, then equilibrate it for 24 hrs. Before characterizing the
samples, stir them for 5 min and then leave them at room temperature.
1.7 To ensure the formation of an equilibrium lipid phase throughout the entire tube,
perform about 10 freeze-thaw cycles and intermittently carry out a centrifugation step as
defined above. Both the DU and PT form highly viscous bulk lipid phases making it difficult
to handle them manually (Figure 1).
Note: The above protocol (section 1) is only necessary, if one would like to compare
nanostructural behaviour (lattice type and dimensions of self-assembly) of dispersed
particles with the bulk lipid phase and/or use it as a control to confirm the retention of
original nanostructure.
6Figure 1: Preparation of O/W particulate emulsion with fluid consistency from highly viscous lipid
phase using high energy input (ultrasonication) and using different CNT-stabilizers, namely SWCNT,
MWCNT-OH, MWCNT-COOH (figure reproduced from reference [50] with permission from The Royal
Society of Chemistry).
2. Preparation of surfactant stabilized lipid particles
2.1 Prepare a 0.2% (w/w) surfactant (pluronic F127) solution in water.
2.1.1 Dissolve 200 mg of the surfactant (white fluffy powder) in 100 mL ultrapure water by
stirring it for 20-30 min (on a magnetic plate using a magnetic stirrer bar). Pluronic F127 is a
non-ionic surfactant and is commonly used as emulsion stabilizer. It is a triblock copolymer
of PEO99 -PPO67-PEO99, and hence takes long time to dissolve in water.
2.2 Add 500 mg of molten DU or PT (using a Pasteur glass pipette) to a glass vial
(scintillation soda-lime fitted with foil lined urea cap, 20 mL).
2.3 Add 9.5 g of the 0.2% F127 solution.
2.4 On the probe ultrasonication machine, tightly clamp the vial to the retort stand jaw
(Retort Stand Set with stand, clamp, base, rod, rubber 3 jaw and bosshead), so that it can
withstand the vibrations generated by sonication.
2.5 Insert the solid titanium alloy probe (13 mm diameter x 139 mm length) attached to
the Cell Sonicator. Adjust the height and position of the vial to ensure that its sides and
bottom are not touching to the probe. A distance of 0.5 cm between the probe tip and the
bottom of the glass vial gives good results.
2.6 Sonicate the mixture for 10 min in a pulsed mode with 1 sec pulse mediated by 1 sec
delay time at 35% (of the maximum) power. The vial becomes very hot due to the heat
generated during sonication. Therefore, allow it to cool down to room temperature before
taking it off the clamp.
2.7 Store the milky-formed dispersion at room temperature for at least 24 h, prior to
further use. This is to ensure its stability against phase separation.
7Note: Before and after using the probe, clean it with acetone, dry with a paper towel, then
rinse it with ultrapure water and dry it once more.
3. Preparation of dispersions of pure CNTs in water
3.1 In two separate beakers, weigh in 4 mg powdered MWCNT-OH and MWCNT-COOH,
both of which are black in color.
3.2 Add 500 mL ultrapure water to each beaker. Using a probe ultrasonicator sonicate
the mixtures for 2 min in a continuous pulse mode at 40% (of the maximum) power. The
resulting concentration of the MWCNT dispersion is 8 µg/mL (stock solution).
3.3 Dilute the MWCNT stock solution with appropriate amounts of ultrapure water to
achieve 6.25, 5, 4, 2 µg/mL MWCNT dispersions.
3.4 Sonicate these dispersions as described before (see 3.2).
3.5 Similarly, disperse 3 mg of powdered SWCNT (also black in color) in 500 mL ultrapure
water to make a 6 µg/mL SWCNT dispersion (stock solution).
3.6 Dilute the SWCNT stock solution and sonicate them as described above (see 3.2) to
obtain 0.5, 0.4, 0.3125, 0.2 µg/mL SWCNT dispersions.
Note: All dispersions are clear for about 30 min, after which the CNTs start to settle at the
bottom.
4 Preparation of CNT-stabilized nanostructured lipid particles (Figure 1)
4.1 Weigh in 500 mg of the molten DU into a glass vial.
4.2 Add 9.5 mL of the 6 µg/mL SWCNT dispersion to the vial.
4.3 Sonicate the CNT-DU mixture using the same parameters as used for making pure
CNT dispersions (see 3.2). Upon cooling to room temperature, the CNT-stabilized lipid
particles with conserved internally self-assembled nanostructure will be ready.
4.4 In a similar way, prepare the lipid particles using the 0.4 µg/mL and 0.2 µg/mL
SWCNT dispersions.
4.5 Follow the protocols 4.1 to 4.4 to make lipid particles using MWCNT-OH and
MWCNT-COOH but using different concentrations, namely 8, 4 and 2 µg/mL of CNT.
4.6 Similarly, prepare three different CNT-PT dispersions using 4 µg/mL MWCNT-OH and
MWCNT-COOH as well as 0.4 µg/mL SWCNT. Note that the CNT-PT dispersions require less
8power (35% of the maximum) but longer time (15 min) in a continuous pulse mode. Cool the
dispersions to room temperature and leave them for 24 h before characterizing them.
Note: Sonication parameters may differ for different lipids (as for DU and PT here) and for
different compositions; they need to be optimized to achieve well-stabilized dispersions.
5 Monitoring the stability of the CNT-stabilized lipid dispersions
5.1 Monitor the stability of the dispersions by visual observation: check if the dispersions
are destabilized or if lumps have formed in the dispersions.
5.2 Take photos (with digital camera) at regular intervals. For instance, take pictures of
dispersions every day in the first week, then every other day for a week followed by once a
week for the next two weeks, and finally once a month as per requirement.
Representative Results:
The following results represent a) the stability of dispersions, b) the size distribution of lipid
particles, c) the type of self-assembly and d) the evidence for lipid coating of the CNTs.
The stability of dispersions (Figure 2) was monitored using a 5 MP camera with auto-focus
and LED flash.
Figure 2. Schematics of CNT types a) MWCNT-OH, b) MWCNT-COOH and c) SWCNT and pictures of
the corresponding emulsions. Stable emulsions were obtained only in a certain region (shaded)
where the CNT to lipid ratio was optimum; below and above stable emulsion did not form because
of a too little or too great amount of CNTs, respectively. An arrow indicates a typical CNT lump in an
unstable emulsion. These measurements were performed for a range of DU-CNT dispersions;
representative ones are shown here (figure reproduced from reference [50] with permission from
The Royal Society of Chemistry).
9Small angle X-ray scattering (SAXS) patterns were recorded in order to determine the lattice
type of the inner nanostructure of the stabilized isasomes (Figure 3a). The SAXSpace camera
is connected to an analytical X-ray generating equipment (ISO-DEBYEFLEX3003) with a
sealed-tube Cu-anode operating at 40 kV and 50 mA. The X-ray tube is chilled with a closed
water circuit. The SAXSpace collimation block unit transforms the divergent polychromatic
X-ray beam into a vertically focused line shaped beam of Cu-Kɲ radiation with a wavelength,
ʄ ?ŽĨ ? ? ? ? ?Ŷŵ ?&ŽƌƚŚĞ^y^ĞǆƉĞƌŝŵĞŶƚƐƚŚĞŚŝŐŚƌĞƐŽůƵƚŝŽŶŵŽĚĞǁĂƐĐŚŽƐĞŶ ?ǁŚŝĐŚ
permits to detect a minimum scattering vector, qmin, of 0.04 nm
-1 (qA? ? ?ʋ ?ʄ ?ƐŝŶɽ ?ǁŚĞƌĞ ?ɽ
is the scattering angle). A semi-transparent beam stop enables to record the attenuated
primary beam profile for the exact determination of the zero scattering vector and
transmission correction. Each of the studied samples is enclosed in the same vacuum-tight,
reusable 1 mm quartz capillary to guarantee exactly the same scattering volume. The
capillary was placed in the temperature controlled sample stage equipped with Peltier
elements, which is connected to a water cooling thermostat to get rid of the excess heat. All
experiments were performed at 25 °C with a temperature stability of 0.1 °C. A vacuum
pump was used to evacuate the sample chamber achieving a minimum pressure of ~1 mbar.
The 1D scattering patterns were recorded with a micro-strip X-ray detector. This detector is
single photon counting and has a sensitive area of 64×8 mm2 comprising 1280 channels each
with a channel size of 0.05 × 8 mm (v × h). The sample-detector distance was 317.09 mm.
Each sample was exposed three times for 300 sec, and their integrated scattering profiles
were averaged.
The SAXStreat software was employed to correct the scattering patterns with respect to the
position of the primary beam. The SAXS data was further transmission-corrected by setting
the attenuated scattering intensity at q = 0 to unity and the background was subtracted
using the SAXSQuant software. The scattering vector q was calibrated with silver-behenate,
which has a known lattice spacing of 5.84 nm69. All recorded diffraction patterns could be
indexed with the space group Pn3m (diamond bicontinuous cubic phase), in which the 110,
111, 200, 211, 220 and 221 reflections were identified (Figure 3a). The lattice parameter, a,
for Pn3m phase was determined by linear regression applying the following lattice equation
a = ϮʋͬƋhkl × я;Ś2 + k2 + l2) (1)
where h, k and l are the Miller indices.
The size and size distribution of dispersed lipid particles (Figure 3b) were determined using a
laser particle size analyer.
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Figure 3. a) SAXS patterns of the Pn3m phase observed for bulk phytantriol (PT) and corresponding
dispersions prepared with 5 wt% PT in excess water using F127 and different CNT stabilizers. The 3-D
schematic diagram shown on the right displays part of the unit cell of Pn3m phase, which is a
bicontinuous cubic phase whose structure is based on double diamond (D) type minimal surface.
Blue arrows indicate aqueous channels meeting at tetrahedral angle whereas hydrophobic and
aqueous regions are colour coded yellow and blue, respectively. Characteristic peaks for Pn3m phase
are indexed as 2, 3, 4, 6, 8, 9 and corresponding Miller indices are shown in the brackets. All
of the above peaks are visible in bulk PT, while the first four reflections are visible for the
dispersions; nonetheless this is sufficient to identify the Pn3m nanostructures and evaluate their
lattice parameters. Peaks highlighted by asterisks indicate the co-existence of Ia3d type cubic phase,
which usually forms with lower water contents, and thus is not seen for dispersions. Lipid particles
with cubic nanostructure in their interior are commonly called as cubosomes. b) Size distribution
of cubosomes prepared using various stabilizers as measured by static light scattering.
The interactions between the CNTs and lipid particles were studied using Raman
spectroscopy (Figure 4). The samples: CNTs, lipid and CNT-stabilized lipid particles were
dehydrated, first using nitrogen gas and then by keeping them in a vacuum desiccator for
about 20 minutes. The spectra were recorded using a Horiba Jobin-Yvon LabRAM HR800
spectrometer equipped with an Andor electromagnet charged coupled device (CCD) for light
detection and a video camera to guide spectral collection. A 532 nm excitation line of
Nd:YAG laser was utilized to collect spectra in the range 1004000 cmAL ?using a grating of
600 g.mmAL ?blazed at 750 nm. 50x long working distance objective with a numerical
ĂƉĞƌƚƵƌĞŽĨ ? ? ? ?ǁĂƐƵƐĞĚƚŽĂĐƋƵŝƌĞƚŚĞƐƉĞĐƚƌĂĂŶĚƚŚĞĐŽŶĨŽĐĂůŚŽůĞǁĂƐƐĞƚĂƚ ? ? ?ʅŵ ?
Before the measurements, the instrument was calibrated to the 520.8 cmAL ?spectral line of
silicon. All spectra were collected at room temperature (25 °C) by placing the sample on
Calcium Fluoride slides. Spectra were acquired using the 532 nm laser and accumulated 5
times with 1% exposure for 10 sec. LabSpec 6 spectroscopy software suite used for pre-
processing the raw data and immediate data interrogation.
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Figure 4. Raman spectra for dehydrated a) pure lipid, MWCNT-COOH and CNT-stabilized lipid
ŶĂŶŽƉĂƌƚŝĐůĞƐĐŽŶƚĂŝŶŝŶŐ ? ? ?ʅŐ ?ŵ>DtEd ?KK, ?ď ?ƉƵƌĞůŝ ŝĚ ?DtEd ?K,ĂŶĚůŝƉŝĚ
ŶĂŶŽƉĂƌƚŝĐůĞƐĐŽŶƚĂŝŶŝŶŐ ? ? ?ʅŐ ?ŵ>DtEd ?K, ?ĂŶĚĐ ?ƉƵƌĞůŝƉŝĚ ?^tEdĂŶĚůŝƉŝĚŶĂŶŽƉĂƌƚŝĐůĞƐ
ĐŽŶƚĂŝŶŝŶŐ ? ? ? ? ? ?ʅŐ ?ŵ>^tEd ?ůůĐƵƌǀĞƐƌĞƉƌĞƐĞŶƚĂŶĂǀĞƌĂŐĞŽĨƚĞŶƐƉĞĐƚƌĂǁŚĞƌĞŝŶƚĞŶƐŝƚŝĞƐ ?ŝŶ
arbitrary units are plotted versus wavelength. Vertical lines are used to guide the eye, and to ease
the detection of the blue shifts in the G and G bands. These experiments were performed for DU. d)
Schematic diagram of possible lipid decoration (self-assembling) on CNT surface (figure reproduced
from reference [50] with permission from The Royal Society of Chemistry).
Discussion:
Stabilization of lipid particles
Three different CNTs are used to stabilize the lipid dispersions; two of which are multi-
walled and functionalized using -OH and -COOH groups, and one is single walled and non-
functionalized (pristine). The CNTs varied in size as follows (diameter x length): MWCNT-
COOH - 9.5 nmx1.5 µm; MWCNT-OH - 8-15 nm x 50 µm; SWCNT - 1-2 nm x 1-3 µm. The
powdered CNTs were dispersed in water by probe ultra-sonication. Aforementioned sizes of
CNTs are likely to decrease further due to ultra-sonication, albeit unevenly. CNT dispersions
in pure water started separating after about 20 min, hence further work was executed
within this time i.e. addition of lipids and second sonication. The latter (ultrasonication
performed on the lipid-CNT mixtures) assists in melting and breaking down large and
inconsistent lipid domains formed during the hydration into sub-micron portions. Dispersing
the bulk lipid in this manner facilitates the equilibrium formation of self-assembled
nanostructures, which otherwise requires rigorous freeze-thaw cycles and/or long time
(days to weeks). The bulk lipid phase breaks into nanoparticles whereas the lipid coated
CNTs supposedly form shells around them. Ultra-sonication enhances the hydrophobic
interactions between the CNTs and the alkyl chains of lipid molecules thereby decorating
CNTs by lipid alkyl chains. Thus coated CNTs stabilize the fragmented lipid phase leading to a
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particulate emulsion. This mutual stabilization avoids the aggregation of CNTs as well as
disperses the lipid particles. Such dispersions are also called Pickering (due to the use of
solid particles) type oil-in-water (O/W) emulsions, where the lipids form an oil phase while
excess water constitutes the continuous emulsion medium (Figure 1). Ultrasonication
parameters (pulse length, delay time and power), physicochemical parameters of a stabilizer
(e.g. dimensions, functionalization), concentration of dispersed phase and composition of
the dispersion (e.g. CNT to lipid ratio) are crucial to guarantee the final stability of the
dispersions and therefore need to be optimized for different (lipid) systems.
Optimization of CNT to lipid ratio for stable emulsions
A wide range of concentrations for each CNT-type (Figure 2) was employed to stabilize the
self-assembled nanostructures obtained from two different lipids. However, homogeneous
and stable emulsions are only formed in a particular range of CNT to lipid ratio; too high
ratios cause aggregation of CNTs, while too low ratios lead to unstable emulsions, because
there are not enough CNTs to accomplish a sufficient particle-surface coverage. Best
ƐƚĂďŝůŝǌĂƚŝŽŶĐŽŶĚŝƚŝŽŶƐǁĞƌĞĨŽƵŶĚǁŝƚŚĐŽŶĐĞŶƚƌĂƚŝŽŶƐďĞƚǁĞĞŶ ? W ?ʅŐ ?ŵ>ĨŽƌDtEd ?
KK,ĂŶĚDtEd ?K, ?ǁŚĞƌĞĂƐĨŽƌ^tEdŝŶƚŚĞƌĂŶŐĞŽĨ ? ? ? W ? ? ? ?ʅŐ ?ŵ> ?
Morphological characterization of lipid particles
The SAXS measurements verify that lipid particles of PT retain the original cubic phase
nanostructure (shown by bulk phase) (Figure 3a). We presume that the cubic phase is also
retained in case of DU particles, however this needs further confirmation as it was not
studied in the current work. The lattice parameter observed for bulk Pn3m phase of PT is
6.84 nm, which upon dispersion increases to 7.1 nm. The lower lattice parameter for bulk
phase is attributed to the lack of excess water, which can be also confirmed by the
coexistence of Ia3d phase (peaks marked by * in Figure 3a). The Ia3d phase is usually found
under limited water conditions. The lattice parameters for Pn3m phase observed for all
dispersed lipid particles (i.e. stabilized by surfactant as well as by all CNT types) are
practically the same indicating excess water conditions. This also rules out the possibility of
CNT-driven disturbances at the molecular level which, otherwise, could have triggered a
change of the lipid phase.
The size distributions of the cubosomes are given by the volume-weighted distributions as
shown in Figure 3b. Although the CNT-stabilized particles display a wide size distribution,
majority of the particles exhibit sizes between 532-760 nm which are comparable to the size
of surfactant stabilized lipid particles (674 nm).
Lipid coating of CNTs
For pure CNTs, typical Raman graphite bands are seen in the Raman spectra. The G band
which corresponds to the in-plane vibration of CC bond, the D band (not shown) which is
ĚƵĞƚŽƚŚĞƉƌĞƐĞŶĐĞŽĨĚŝƐŽƌĚĞƌŝŶĐĂƌďŽŶƐǇƐƚĞŵƐĂŶĚƚŚĞ'഻ďĂŶĚǁŚŝĐŚŝƐĂƚƚƌŝďƵƚĞĚƚŽƚŚĞ
overtone of the D band70 are clearly observed. Upon interaction of CNT with lipid and on
formation of CNT-stabilized lipid particles (compare green and blue curves in Figure 4), a
shift to higher wavenumbers (blue shift) is observed. The observed blue shift, could be due
to: i) high pressure exerted on CNTs during ultrasonication resulting in their dispersion as
opposed to a bundled state when pure70,71, and/or ii) interactions between CNTs and lipid
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molecules via coating of CNTs by lipids (such blue shift has been reported previously by
Douroumis et al.72 for lipid coated SWCNTs).
The decrease in relative intensities of CNT peaks and appearance of lipid signals (from red
curves of pure lipid (Figure 4) further confirms the coating of CNTs by lipid molecules. This
suggests that the hydrophobic interactions between CNTs and alkyl chains of lipid molecules
decorate the CNT surface in such a way that hydrophilic head groups face aqueous regions
thus stabilizing O/W emulsion, as shown by the schematic in Figure 4d.
We have demonstrated a smart and simple method of kinetically stabilizing the O/W type
emulsion of nanostructured lipid particles using various CNTs. Very low concentrations (<10
µg/mL) of CNTs are adequate to stabilize the lipid nanoparticle dispersion, which is
promising specifically for in vivo applications. Decoration of CNTs by lipid molecules is
anticipated to minimize their toxicity while improving the biocompatibility. The prospect of
loading functional molecules within the lipid self-assembly as well as on the CNT surface
provide limitless potential to the CNT-stabilized lipid particles in the area of biomedical
sciences especially in the context of combination therapies against major diseases73.
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